US EditionPublished • loading... • Updated
Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
Summary by hitconsultant.net
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know: – MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on “deep health” solutions that address diseases linked to environmental toxins and synthetic exposures. – Backed by institutional heavyweights like Industry Ventures and the State of New York, the firm plans to deploy checks ranging from $1 million to $4 million into startups that …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
